Structure Therapeutics (GPCR) Change in Acquisitions & Divestments (2022 - 2026)

Structure Therapeutics' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $151.7 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 0.83% year-over-year to $151.7 million; the TTM figure through Mar 2026 stood at $631.8 million (up 36.79% YoY), while the FY2025 annual figure was $630.5 million, up 82.82% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $151.7 million, up from $146.2 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $195.9 million in Q3 2025, with the low at -$92.8 million in Q2 2023.
• The 5-year median for Change in Acquisitions & Divestments is $66.4 million (2024), against an average of $78.8 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 6954.0% in 2023, while the deepest fall reached 983.62% in 2023.
• Structure Therapeutics' Change in Acquisitions & Divestments stood at $19.6 million in 2022, then jumped by 190.82% to $57.0 million in 2023, then jumped by 190.35% to $165.5 million in 2024, then fell by 11.68% to $146.2 million in 2025, then grew by 3.79% to $151.7 million in 2026.
• Business Quant data shows GPCR's Change in Acquisitions & Divestments at $151.7 million in Q1 2026, $146.2 million in Q4 2025, and $195.9 million in Q3 2025.